GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si, a Connecticut-based start-up, today introduced the world’s first next-generation protein sequencing platform at Cowen Healthcare 2020. The Quantum-Si ...

Barcoding technologies that take advantage of the high information content that can be encoded in oligonucleotide sequences have enabled a wide array of applications in biotechnology, particularly ...

Protein sequencing presents different challenges than nucleic acid sequencing, meaning that proteomics has yet to benefit as much as genomics from the next-generation sequencing revolution. However, ...

Proteins, through their diversity, are vital determinants of phenotype and function. Humans possess potentially millions of protein variants (proteoforms), derived through mechanisms including ...

On Wednesday, Quantum-Si Incorporated (NASDAQ:QSI) stock traded over 100% higher after the protein sequencing company announced a collaboration with NVIDIA Corporation (NASDAQ:NVDA) to develop its new ...

Quantum-Si aims to revolutionize protein sequencing but faces significant technological and competitive challenges. Commercial reception to Quantum-Si's solutions has been lukewarm so far, suggesting ...

A technology developed in the laboratory of Prof. Amit Meller from the Technion—Israel Institute of Technology Faculty of Biomedical Engineering marks a significant advancement toward rapid proteome ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma, biotech, and industrial biology. Ainnocence is expanding partnerships, ...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Liberate Bio, a Boston-based ...

Barcoding technologies using the high information content encoded in oligonucleotide sequences have aided various applications in biotechnology, especially when paired with next-generation DNA ...